These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 29439965)
21. Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon. L'Episcopia M; Kelley J; Djeunang Dongho BG; Patel D; Schmedes S; Ravishankar S; Perrotti E; Modiano D; Lucchi NW; Russo G; Talundzic E; Severini C Int J Infect Dis; 2021 Jun; 107():234-241. PubMed ID: 33940188 [TBL] [Abstract][Full Text] [Related]
22. Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia. Al-Farsi HM; Al-Hashami ZS; Bin Dajem SM; Al-Sheikh AA; Al-Qahtani A; Beja-Pereira A; Idris MA; Babiker HA Infect Genet Evol; 2012 Aug; 12(6):1253-9. PubMed ID: 22709478 [TBL] [Abstract][Full Text] [Related]
23. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058 [TBL] [Abstract][Full Text] [Related]
24. A molecular surveillance system for global patterns of drug resistance in imported malaria. Labbé AC; Patel S; Crandall I; Kain KC Emerg Infect Dis; 2003 Jan; 9(1):33-6. PubMed ID: 12533279 [TBL] [Abstract][Full Text] [Related]
25. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo. Ruh E; Bateko JP; Imir T; Taylan-Ozkan A Malar J; 2018 Jan; 17(1):17. PubMed ID: 29316929 [TBL] [Abstract][Full Text] [Related]
26. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya. Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703 [TBL] [Abstract][Full Text] [Related]
27. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran. Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131 [TBL] [Abstract][Full Text] [Related]
28. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season. Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362 [TBL] [Abstract][Full Text] [Related]
29. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity. Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875 [TBL] [Abstract][Full Text] [Related]
30. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261 [TBL] [Abstract][Full Text] [Related]
32. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire. Djaman JA; Mazabraud A; Basco L Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496 [TBL] [Abstract][Full Text] [Related]
33. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania. Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H Malar J; 2006 Oct; 5():94. PubMed ID: 17076899 [TBL] [Abstract][Full Text] [Related]
36. Origins and spread of novel genetic variants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia. Basuki S; Fitriah ; Risamasu PM; Kasmijati ; Ariami P; Riyanto S; Hidayat A; Susilowati D; Iskandar ; Armika B; Budiono ; Dachlan YP; Kanbara H; Uemura H Malar J; 2018 Dec; 17(1):475. PubMed ID: 30558597 [TBL] [Abstract][Full Text] [Related]
37. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests. Rason MA; Ariey F; Rafidimanantsoa L; Andrianantenaina BH; Sahondra Harisoa JL; Randrianarivelojosia M Parasite; 2002 Sep; 9(3):247-53. PubMed ID: 12375368 [TBL] [Abstract][Full Text] [Related]
38. [Molecular surveillance of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in São Tomé and Príncipe]. Tahar R; Djaman J; Ferreira C; Basco L Bull Soc Pathol Exot; 2007 May; 100(2):115-8. PubMed ID: 17727034 [TBL] [Abstract][Full Text] [Related]
39. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka. Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070 [TBL] [Abstract][Full Text] [Related]
40. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR. Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]